Statistics
Publications
23
Citations
1.3K
H-Index
17
Active since
1984
Mark Schneider is an author at National Institutes of Health specializing in immunology, cancer immunotherapy, and immunotherapy.
Publications per year
1984–2021
23
23
Immunomodulatory properties of recombinant murine and human tumor necrosis factor.
James E. Talmadge, Hamblin Phillips, Mark Schneider et al. · PubMed · 1988 · 129 citations
Immunomodulatory and therapeutic properties of bestatin in mice.
James E. Talmadge, Barbara Lenz, Robin Pennington et al. · PubMed · 1986 · 89 citations
Medicine, Immunology, Oncology +17
1–5 of 23